Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts. (Q47854934)
Jump to navigation
Jump to search
scientific article published in July 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts. |
scientific article published in July 1998 |
Statements
1 reference
Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts. (English)
1 reference
J Baselga
1 reference
L Norton
1 reference
J Albanell
1 reference
Y M Kim
1 reference
J Mendelsohn
1 reference
1 July 1998
1 reference
1 reference
58
1 reference
13
1 reference
2825-2831
1 reference
Identifiers
1 reference